Fate Therapeutics Inc. sell StockNews.com
Start price
10.03.23
/
50%
€4.55
Target price
10.03.24
-
Performance (%)
60.53%
End price
11.03.24
€7.31
Summary
This prediction ended on 11.03.24 with a price of €7.31. The SELL prediction by StockNews_com for Fate Therapeutics Inc. was trending in the completely wrong direction and closed with a performance of 60.53%. StockNews_com has a follow-up prediction for Fate Therapeutics Inc. where he still thinks Fate Therapeutics Inc. is a Sell. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Fate Therapeutics Inc. | -3.693% | -3.693% | 16.989% | -81.304% |
| iShares Core DAX® | 0.231% | -2.413% | 15.337% | 45.097% |
| iShares Nasdaq 100 | 1.663% | -1.658% | 31.087% | 76.365% |
| iShares Nikkei 225® | -0.208% | -2.502% | 43.625% | 49.585% |
| iShares S&P 500 | 1.067% | -1.579% | 24.346% | 57.069% |
Comments by StockNews_com for this prediction
In the thread Fate Therapeutics Inc. diskutieren
Fate Therapeutics, Inc. (NASDAQ: FATE) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for FATE provided by MarketBeat
In the thread Trading Fate Therapeutics Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Current prediction by StockNews_com for Fate Therapeutics Inc.
Stopped prediction by StockNews_com for Fate Therapeutics Inc.
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€4.15
11.05.24
11.05.24
-
11.05.25
11.05.25
-76.44%
12.05.25
12.05.25
